Hemab Therapeutics Holdings, Inc Common Stock
Price & Volume
Stats
See more52W Range | $18-$55.42 |
Market Cap | $2.1B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.69 |
News
See moreAbout
CEO | Dr. Benny Sorensen M.D., Ph.D. |
CFO | Mr. Mads Nikolaj Behrndt-Eriksen M.Sc. |
Address | 101 Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |